Blum Holdings AI Stock Analysis
Want to see BLMH full AI Analyst Report?
Blum Holdings (BLMH) AI Stock Analysis
Blum Holdings
(Other OTC:BLMH)
BLMH scores near the bottom of the range, driven primarily by a highly distressed financial profile: a roughly 70% revenue decline from 2022, deeply negative operating margins, a TTM net loss equal to about 62% of sales, negative shareholders' equity of -$11.0M, and continued cash burn that leaves the company reliant on outside financing. Technicals reinforce the caution, with the stock below all key moving averages and negative MACD momentum amid very high volatility (beta 2.29). Valuation provides no offset given negative earnings and no dividend. The credible positives — gross margin improvement to about 44%, debt reduced from $79.4M to $7.9M, and a sharply lower cash burn — show management is stabilizing the business, but until sustained revenue growth and positive operating cash flow emerge, the risk of further dilution or liquidity strain dominates.
Blum Holdings (BLMH) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.93M
- Dividend Yield
- ―
- Average Volume (3M)
- 4,868
- Price to Earnings (P/E)
- -0.4
- Beta (1Y)
- 2.36
- Revenue Growth
- 19.98%
- EPS Growth
- -180.06%
- Country
- US
- Employees
- 133
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Specialty Retail
Blum Holdings Business Overview & Revenue Model
Company Description
Blum Holdings, Inc. is an entity operating within California's regulated cannabis market, comprehensively addressing both medical and adult-use demands. The company's multifaceted involvement encompasses the cultivation, production, distribution, and...
Blum Holdings Financial Statement Overview
Summary
Severely distressed financial profile. Revenue has collapsed roughly 70% from its 2022 peak to $15.8M TTM, operating margins are around -48%, and the TTM net loss of $9.4M equals about 62% of sales. Shareholders' equity is negative at -$11.0M and widening, making solvency and dilution risk elevated. Operating and free cash flow remain negative (-$2.4M and -$2.5M), with losses being largely cash losses. The 2024 'profit' was driven by one-time non-operating gains rather than operations. Offsetting positives are incremental: gross margin has improved to roughly 44%, total debt has been cut from $79.4M to $7.9M, cash burn has shrunk dramatically from -$21.9M in 2021, and revenue has stabilized modestly over the last two periods.
Income Statement
13Very NegativeBalance Sheet
15Very NegativeCash Flow
22Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.76M | 14.91M | 12.99M | 33.23M | 52.02M | 42.12M |
| Gross Profit | 6.59M | 6.00M | 6.21M | 14.00M | 16.90M | 11.02M |
| EBITDA | -6.31M | -6.30M | 22.00M | -2.26M | -180.51M | -30.07M |
| Net Income | -9.39M | -7.96M | 33.10M | -14.13M | -188.93M | -31.27M |
Balance Sheet | ||||||
| Total Assets | 43.57M | 44.52M | 24.82M | 32.07M | 40.51M | 271.82M |
| Cash, Cash Equivalents and Short-Term Investments | 590.00K | 813.00K | 1.04M | 862.00K | 1.20M | 6.70M |
| Total Debt | 7.94M | 7.50M | 4.79M | 37.70M | 49.56M | 79.41M |
| Total Liabilities | 51.67M | 48.74M | 29.56M | 77.77M | 77.05M | 125.34M |
| Stockholders Equity | -11.05M | -7.17M | -6.75M | -45.70M | -36.54M | 142.63M |
Cash Flow | ||||||
| Free Cash Flow | -2.45M | -2.53M | -2.15M | -1.29M | -9.76M | -21.93M |
| Operating Cash Flow | -2.43M | -2.50M | -2.14M | -965.00K | -7.83M | -17.96M |
| Investing Cash Flow | 65.00K | -971.00K | 2.03M | 462.00K | 19.61M | 21.67M |
| Financing Cash Flow | 2.59M | 3.25M | 143.00K | 539.00K | -17.27M | 4.50M |
Blum Holdings Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BLMH, the sentiment is Negative. The current price of 0.14 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.18, and below the 200-day MA of 0.22, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 42.05 is Neutral, neither overbought nor oversold. The STOCH value of 5.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BLMH.
Blum Holdings Risk Analysis
Blum Holdings disclosed 56 risk factors in its most recent earnings report. Blum Holdings reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksBlum Holdings Peers Comparison
Overall Rating
AYTU62Neutral
SNOA54Neutral
YCBD43Neutral
BLMH39Underperform
IMCC39Underperform
PRFX37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 62Neutral | $19.35M | -1.30 | -52.89% | ― | -13.27% | 27.11% | |
| 54Neutral | $5.52M | -1.20 | -36.40% | ― | 38.69% | 58.68% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 43Neutral | $4.19M | -1.22 | -34.25% | ― | 10.01% | 95.01% | |
| 39Underperform | $4.51M | -0.40 | 107.69% | ― | 19.98% | -180.06% | |
| 39Underperform | $936.11K | -0.04 | 528.80% | ― | -35.33% | -127.87% | |
| 37Underperform | $2.38M | -0.07 | -72.87% | ― | ― | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| BLMH | Blum Holdings Inc | 0.14 | -0.49 | -77.30% | |
| SNOA | Sonoma Pharmaceuticals, Inc. | 1.09 | -2.53 | -69.89% | |
| AYTU | Aytu BioScience | 1.78 | -0.20 | -10.10% | |
| YCBD | Cbdmd INc | 0.37 | -0.23 | -37.67% | |
| PRFX | Painreform Ltd. | 0.78 | -3.64 | -82.30% | |
| IMCC | Im Cannabis Corp | 0.57 | -29.39 | -98.10% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 24, 2026
